Cargando…
Antitumor effect of toosendanin on oral squamous cell carcinoma via suppression of p-STAT3
BACKGROUND: Toosendanin (TSN) exhibits potent antitumor activity against various tumor cell lines. However, its efficacy against oral squamous cell carcinoma (OSCC) remains unknown. Here, we investigated the effects of TSN on OSCC cells in vitro and verified them in vivo using a patient-derived xeno...
Autores principales: | Wu, Ye, Chen, Lingling, Feng, Cheng, Wang, Tao, He, Shaohai, Zheng, Dali, Lin, Lisong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10634166/ https://www.ncbi.nlm.nih.gov/pubmed/37946196 http://dx.doi.org/10.1186/s12903-023-03602-x |
Ejemplares similares
-
Toosendanin demonstrates promising antitumor efficacy in osteosarcoma by targeting STAT3
por: Zhang, T, et al.
Publicado: (2017) -
Correction: Toosendanin demonstrates promising antitumor efficacy in osteosarcoma by targeting STAT3
por: Zhang, T., et al.
Publicado: (2019) -
Toosendanin targeting eEF2 impedes Topoisomerase I & II protein translation to suppress esophageal squamous cell carcinoma growth
por: Jia, Xuechao, et al.
Publicado: (2023) -
Toosendanin Induces Hepatocyte Damage by Inhibiting Autophagic Flux via TFEB-Mediated Lysosomal Dysfunction
por: Luo, Li, et al.
Publicado: (2022) -
Toosendanin induces the apoptosis of human Ewing's sarcoma cells via the mitochondrial apoptotic pathway
por: Gao, Tian, et al.
Publicado: (2019)